Alzheimer’s Drug Can Be Safely Administered In Memory Clinics, Study Says
THURSDAY, May 15, 2025 (HealthDay News) — The 2023 approval of the first drug shown to slow the progression of Alzheimer’s disease came with no small amount of concern from skeptics. Lecanemab (Leqembi) modestly slows Alzheimer’s by helping the body flush out amyloid beta proteins associated with toxic plaques in theContinue Reading